The combination of anti-TNF-α and anti-IFN-γ blocking antibodies reversed the tumor-suppressing effect of TSLP induction and resulted in an accelerated breast tumor growth compared with IgG-treated group (p < 0.0001, Figure 4D). The gene discussed is IFNG; the disease is breast neoplasm.